IP Group news 0

IP Group plc (LSE: IPO) ("IP Group" or "the Company" or "the Group"), the UK's
leading university intellectual property commercialisation company, announces that it has today received notification from Alan Aubrey, Chief Executive Officer, and David Norwood, Special Projects Director, regarding the purchase of Ordinary Shares in the Company.

The Company was notified on 26 November 2008 that Alan Aubrey, Chief Executive Officer, purchased in aggregate 21,725 Ordinary Shares in the Company at 34.0 pence per share.

The Company was notified on 26 November 2008 that David Norwood, Special Projects Director, purchased in aggregate 178,275 Ordinary Shares in the Company at 34.0 pence per share.

The full text of this announcement is available on RNS.

For further information, please contact:  
 
IP Group plc        
 
Alan Aubrey, Chief Executive Officer  020 7444 0050 
 
Liz Vaughan-Adams (Communications)                                   020 7444
0062/07979853802 
 
Financial Dynamics 
 
Ben Atwell, John Dineen    020 7831 3113 
 
Notes for Editors 
 
About IP Group 
 
IP Group is an intellectual property (IP) commercialisation company that specialises in commercialising university technology. Founded in 2001, IP Group listed on AIM in October 2003 and moved to the Official List in June 2006. It has made two acquisitions to date - Techtran, a company set up to commercialise university intellectual property under a long term contract with the University of Leeds, in 2005 and Top Technology Ventures, an investment adviser to early stage technology venture capital funds, in 2004.

IP Group has formed long-term partnerships with ten universities - the University of Oxford, King's College London, CNAP/University of York, the University of Leeds, the University of Bristol, the University of Surrey, the University of Southampton, Queen Mary (University of London), the University of Bath and the University of Glasgow.

The Company's portfolio is diverse with exposure to five main sectors - Energy & Renewables, Healthcare & Life Sciences: Non-therapeutics, Healthcare & Life Sciences: Therapeutics, IT & Communications and Chemicals & Materials. To date, ten portfolio companies have listed on the AIM market of the London Stock Exchange, one on PLUS Markets and there have been two trade sales. IP Group also established three 'Modern-themed' subsidiaries - Modern Biosciences, Modern Water and Modern Waste. Modern Water was the first of these subsidiaries to float on AIM in June 2007.

For more information, please visit our website at www.ipgroupplc.com.